Company:  BIONIK LABORATORIES CORP. (BNKL)
Form Type:  10-Q
Filing Date:  2/11/2019 
CIK:  0001508381 
Address:  483 BAY STREET
N105
 
City, State, Zip:  TORONTO,  M5G2C9 
Telephone:  1.416.640.7887 
Fiscal Year:  03/31 
Last Trade
Last Trade: 
$3.19  
Change: 
0.00 (0.00%)  
Trade Time: 
Jul 16  
Market Cap: 
$11.81M
Trade BNKL now with 

© 2019  
Description of Business
Bionik Laboratories Corp. is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and innovative robotics technology to help individuals from hospital to home to regain mobility, enhance autonomy, and regain self-esteem. The Company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver greater recovery for patients with neurological or mobility impairments. These technologies allow large amounts of data to be collected and processed in real-time, enabling appropriately challenging and individualized therapy during every treatment session. This is the foundation of the InMotion(TM) therapy.
Register and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      Item 1. Unaudited Financial Statements
        BALANCE SHEET
        Subsequent Events (Note 15)
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
      Item 2. Management's Discussion and Analysis of Financial ...
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures
    PART II - OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 1A. Risk Factors
      Item 2. Unregistered Sales of Equity Securities and Use of ...
      Item 3. Defaults Upon Senior Securities.
      Item 4. Mine Safety Disclosures
      Item 5. Other Information
      Item 6. Exhibits
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION PURSUANT TO SECTION 302 OF
  EXHIBIT 31.2
    CERTIFICATION PURSUANT TO SECTION 302 OF
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350